ATLANTA, Nov. 19, 2015 (GLOBE NEWSWIRE) -- The 11th World Stem Cell Summit & RegMed Capital Conference #WSCS15 brings together over 1,200 scientists, clinicians, investors, bioethicists, philanthropists, companies, regulators and patient advocates from 40 countries together in Atlanta to accelerate the discovery and development of lifesaving therapies and cures. A mission driven event that provides a window to the world for stem cell and regenerative medicine, the three-day, 7-track conference showcases 90 sessions on topics ranging from new discoveries and clinical trials, to the ethics and laws surrounding stem cells and regenerative medicine to hot topics and patient stories.

Conference Details:

World Stem Cell Summit: Thursday, December 10 to Saturday, December 12, 2015

Regenerative medicine and geopolitics. Japanese companies have targeted two key U.S. stem cell companies for takeover. Hear from top Japan industry, academic and regulatory leaders on Japan's emergence as a leader in the field along with strategic leaders from 5 different continents discussing major developments in their countries.

Innovative technologies are creating profound ethical and legal dilemmas. Should we ban gene-editing in human embryos when seeking to cure disease? Stem cells of threatened species are being stored in a "Frozen Zoo." Is it ethical or wise to clone endangered creature or de-extinct a species? Should we clone a mammoth?

The "here and now" using stem cells in the operating room. Learn how the U.S. military plans to heal wounded warriors using regenerative medicine. Should consumers beware of stem cell clinics? How are stem cells are being used in sports medicine?

Heal the suffering children. How are we treating afflictions with cord blood and neural stem cells

Stem cells in space. How is microgravity and biological research on the International Space Station shaking up research?

Patient support and advocacy underpin all advancements in the field. Human interest stories abound as the Summit hosts numerous patients, their families and representatives from the afflicted communities.

The Genetics Policy Institute (GPI), a nonprofit organization, produces the World Stem Cell Summit & RegMed Capital Conference, the flagship meeting of the international stem cell community. The Summit is organized by Genetics Policy Institute/Regenerative Medicine Foundation, The Georgia Center for Regenerative Engineering & Medicine (Emory University, Georgia Tech, University of Georgia), Mayo Clinic, Kyoto University Institute for Cell-Material Sciences (iCeMS), BioBridge Global, Wake Forest Institute for Regenerative Medicine and The New York Stem Cell Foundation. The goal of the Summit is to accelerate the discovery and development of lifesaving cures and therapies, bringing global stakeholders together to solve global challenges. The Summit forges collaborations to advance cell therapies, while creating a supportive environment of regulation, legislation, financing, reimbursement and patient advocacy.

For more information, visit worldstemcellsummit.com.

Follow @WSCSummit on Twitter.

The recently merged, Genetics Policy Institute/Regenerative Medicine Foundation, is a 501c3 nonprofit public interest organization, with the mission to promote public awareness, societal support and public policy initiatives for the fields of regenerative medicine, stem cell research and other advanced therapies, thereby accelerating their application in medicine for the purpose of delivering cures. We pursue this mission through production of its flagship annual World Stem Cell Summit & RegMed Capital Conference, publication of the annual World Stem Cell Report and newsletters, Stem Cell Action Awards, the Stem Cell Action Coalition, social media campaigns, special projects, speaking engagements, teaching initiatives and strategic collaborations. See more on at www.genpol.org.

Newswire Distribution Network & Management

About Us

GlobeNewswire, a Nasdaq company, is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.